TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment ...

The LEGEND trial showed a 62% complete response (CR) rate with the non-viral gene therapy at six months in NMIBC patients who ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

Hormone therapy could improve quality of life for premenopausal women with gynecologic cancers who have had bilateral ...

The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...

The experts agreed that perioperative approaches in muscle-invasive bladder cancer continue to evolve. Ongoing data will ...

A global study found that women with early-stage, intermediate-risk breast cancer who have a mastectomy and modern drug ...

A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model ...

Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the online publication of ...

Projection is one of the oldest defenses in psychology. When people cannot face fear, anger, or envy, they project those ...

Experts say the increase in lung cancer among non-smokers is mainly due to radon, air pollution, and genetic mutations ...